| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 14 Feb 25 | AARD Aardvark Therapeutics, Inc. Common Stock | Common Stock | Buy | Acquire P | Yes | No | 16 | 187,500 | 3.00 mm | 987,689 |
| 14 Feb 25 | AARD Aardvark Therapeutics, Inc. Common Stock | Common Stock | Conversion | Acquire C | Yes | No | 0 | 800,189 | 0.00 | 800,189 |
| 14 Feb 25 | AARD Aardvark Therapeutics, Inc. Common Stock | Series C Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 6,780,810 | 0.00 | 0 |
| 8 Feb 25 | HLXB Helix Acquisition Corp. II | Class B Ordinary Shares Class A Ordinary Shares | Other | Dispose J | Yes | No | 0 | 30,000 | 0.00 | 4,480,000 |
| 4 Nov 24 | DRUG Bright Minds Biosciences | Common Shares | Buy | Acquire P | Yes | No | 21.7 | 184,331 | 4.00 mm | 1,059,331 |
